feed,title,long_url,short_url
MedRxiv,Transparency and reporting characteristics of COVID-19 randomized controlled trials,https://medrxiv.org/cgi/content/short/2022.02.03.22270357v1?rss=1,https://bit.ly/3HvGDsg
MedRxiv,Efficacy and safety of nitazoxanide combined with ritonavir-boosted atazanavir for the treatment of mild to moderate COVID-19,https://medrxiv.org/cgi/content/short/2022.02.03.22270152v1?rss=1,https://bit.ly/3L92eJb
MedRxiv,"OraSure InteliSwab Rapid Antigen Test performance with the SARS-CoV-2 Variants of Concern Alpha, Beta, Gamma, Delta, and Omicron",https://medrxiv.org/cgi/content/short/2022.02.02.22270254v1?rss=1,https://bit.ly/3B16aHl
MedRxiv,Equitable COVID-19 vaccine prioritization: front-line workers or 65-74 year olds?,https://medrxiv.org/cgi/content/short/2022.02.03.22270414v1?rss=1,https://bit.ly/3HthtdG
MedRxiv,"Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities: surveillance results from southern Sweden",https://medrxiv.org/cgi/content/short/2022.02.03.22270389v1?rss=1,https://bit.ly/32YcKSf
MedRxiv,Effectiveness of the inactivated COVID-19 vaccine (CoronaVac) in adult population in Indonesia,https://medrxiv.org/cgi/content/short/2022.02.02.22270351v1?rss=1,https://bit.ly/332qADk
MedRxiv,"Modeling Vaccinations, Virus Variants and Lockdown: Early guidance for Sars-Cov-2 health policies in India",https://medrxiv.org/cgi/content/short/2022.02.02.22270353v1?rss=1,https://bit.ly/3Hx2IXh
MedRxiv,Fatality assessment and variant risk monitoring for COVID-19 using three new hospital occupancy related metrics,https://medrxiv.org/cgi/content/short/2022.02.03.22270417v1?rss=1,https://bit.ly/35RWbbS
MedRxiv,RISK STRATIFICATION OF PATIENTS WITH COVID-19 DISEASE THROUGH THE USE OF CLINICAL SCORES IN AN EMERGENCY DEPARTMENT. A review of the literature,https://medrxiv.org/cgi/content/short/2022.02.03.22270401v1?rss=1,https://bit.ly/32XE0Ai
